Keybanc Maintains Overweight on LivaNova, Raises Price Target to $92

Benzinga Newsdesk www.benzinga.com Positive 82.6%

Neg 0% Neu 0% Pos 82.6%

Keybanc analyst Brett Fishbin maintains LivaNova (NASDAQ:LIVN) with a Overweight and raises the price target from $83 to $92.